Cargando…
Increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism
There are no recommended diagnostic criteria for transient congenital hypothyroidism (CH) during early childhood. In this study, we aimed to identify the factors that distinguish permanent (P)- and transient (T)-CH. We retrospectively analyzed the clinical, biochemical, and imaging data of 42 childr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534519/ https://www.ncbi.nlm.nih.gov/pubmed/33088013 http://dx.doi.org/10.1297/cpe.29.143 |
_version_ | 1783590328175951872 |
---|---|
author | Yamamura, Hinako Kokumai, Takahide Furuya, Akiko Suzuki, Shigeru Tanahashi, Yusuke Azuma, Hiroshi |
author_facet | Yamamura, Hinako Kokumai, Takahide Furuya, Akiko Suzuki, Shigeru Tanahashi, Yusuke Azuma, Hiroshi |
author_sort | Yamamura, Hinako |
collection | PubMed |
description | There are no recommended diagnostic criteria for transient congenital hypothyroidism (CH) during early childhood. In this study, we aimed to identify the factors that distinguish permanent (P)- and transient (T)-CH. We retrospectively analyzed the clinical, biochemical, and imaging data of 42 children with a definitive diagnosis of P- or T-CH by re-evaluation tests at our institution from November 1986 to October 2019. Patients who continued levothyroxine (L-T(4)) treatment after the re-evaluation tests were classified as group P (n = 19), while patients who were diagnosed with T-CH and discontinued L-T(4) treatment were classified as group T (n = 23). Initial testing performed during infancy showed that the mean serum TSH and free T4 (FT4) levels did not differ significantly between groups P and T. None of the patients in group T required an increased dosage of L-T(4) at the age of 3 yr and above while 85% of the patients in group P required increased dosages of L-T(4). Hence, T-CH was suspected in patients who did not require an increase in L-T(4) dosage at the age of 3 yr and above. |
format | Online Article Text |
id | pubmed-7534519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Japanese Society for Pediatric Endocrinology |
record_format | MEDLINE/PubMed |
spelling | pubmed-75345192020-10-20 Increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism Yamamura, Hinako Kokumai, Takahide Furuya, Akiko Suzuki, Shigeru Tanahashi, Yusuke Azuma, Hiroshi Clin Pediatr Endocrinol Original Article There are no recommended diagnostic criteria for transient congenital hypothyroidism (CH) during early childhood. In this study, we aimed to identify the factors that distinguish permanent (P)- and transient (T)-CH. We retrospectively analyzed the clinical, biochemical, and imaging data of 42 children with a definitive diagnosis of P- or T-CH by re-evaluation tests at our institution from November 1986 to October 2019. Patients who continued levothyroxine (L-T(4)) treatment after the re-evaluation tests were classified as group P (n = 19), while patients who were diagnosed with T-CH and discontinued L-T(4) treatment were classified as group T (n = 23). Initial testing performed during infancy showed that the mean serum TSH and free T4 (FT4) levels did not differ significantly between groups P and T. None of the patients in group T required an increased dosage of L-T(4) at the age of 3 yr and above while 85% of the patients in group P required increased dosages of L-T(4). Hence, T-CH was suspected in patients who did not require an increase in L-T(4) dosage at the age of 3 yr and above. The Japanese Society for Pediatric Endocrinology 2020-10-03 2020 /pmc/articles/PMC7534519/ /pubmed/33088013 http://dx.doi.org/10.1297/cpe.29.143 Text en 2020©The Japanese Society for Pediatric Endocrinology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Yamamura, Hinako Kokumai, Takahide Furuya, Akiko Suzuki, Shigeru Tanahashi, Yusuke Azuma, Hiroshi Increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism |
title | Increase in doses of levothyroxine at the age of 3 years and above is useful
for distinguishing transient and permanent congenital hypothyroidism |
title_full | Increase in doses of levothyroxine at the age of 3 years and above is useful
for distinguishing transient and permanent congenital hypothyroidism |
title_fullStr | Increase in doses of levothyroxine at the age of 3 years and above is useful
for distinguishing transient and permanent congenital hypothyroidism |
title_full_unstemmed | Increase in doses of levothyroxine at the age of 3 years and above is useful
for distinguishing transient and permanent congenital hypothyroidism |
title_short | Increase in doses of levothyroxine at the age of 3 years and above is useful
for distinguishing transient and permanent congenital hypothyroidism |
title_sort | increase in doses of levothyroxine at the age of 3 years and above is useful
for distinguishing transient and permanent congenital hypothyroidism |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534519/ https://www.ncbi.nlm.nih.gov/pubmed/33088013 http://dx.doi.org/10.1297/cpe.29.143 |
work_keys_str_mv | AT yamamurahinako increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism AT kokumaitakahide increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism AT furuyaakiko increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism AT suzukishigeru increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism AT tanahashiyusuke increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism AT azumahiroshi increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism |